VaxArray Study Published in Vaccine VaxArray Flu Vaccine Potency Study Published in Vaccine InDevR’s Study, [...] VaxArray Study Published in VaccineInDevR Admin2021-01-05T11:35:32-07:00
InDevR Licenses FDA Influenza Antibodies InDevR Licenses FDA Influenza Antibodies for VaxArray™ InDevR’s access to [...] InDevR Licenses FDA Influenza AntibodiesInDevR Admin2021-01-05T11:35:41-07:00
Dr. Rowlen Presented at HHS InDevR CEO, Dr. Kathy Rowlen, gave a presentation at HHS [...] Dr. Rowlen Presented at HHSInDevR Admin2020-10-23T12:36:35-06:00
ISIRV Options IX for the Control of Influenza InDevR participated in the recent ISIRV Options IX Conference. In addition to [...] ISIRV Options IX for the Control of InfluenzaInDevR Admin2021-01-05T11:35:55-07:00
Dawn Bitz Joins InDevR InDevR Appoints Dawn Bitz as Chief Commercial Officer Addition Strengthens [...] Dawn Bitz Joins InDevRInDevR Admin2021-01-05T11:36:10-07:00